1303 related articles for article (PubMed ID: 33113210)
1. Is there a role for childhood vaccination against COVID-19?
Eberhardt CS; Siegrist CA
Pediatr Allergy Immunol; 2021 Jan; 32(1):9-16. PubMed ID: 33113210
[TBL] [Abstract][Full Text] [Related]
2. [Do we need a pediatric COVID-19 vaccine?].
Eberhardt CS; Siegrist CA
Rev Med Suisse; 2021 Feb; 17(726):353-357. PubMed ID: 33599412
[TBL] [Abstract][Full Text] [Related]
3. The Century of mRNA Vaccines: COVID-19 Vaccines and Allergy.
Ortega RodrÃguez NR; AudÃcana Berasategui MT; de la Hoz Caballer B; Valero Santiago A
J Investig Allergol Clin Immunol; 2021 Feb; 31(1):89-91. PubMed ID: 33393485
[No Abstract] [Full Text] [Related]
4. Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines.
Schulze-Koops H; Specker C; Skapenko A
RMD Open; 2021 Feb; 7(1):. PubMed ID: 33627439
[TBL] [Abstract][Full Text] [Related]
5. Herd immunization with childhood vaccination may provide protection against COVID-19.
Yu Y
Acta Microbiol Immunol Hung; 2020 Sep; 67(3):198-200. PubMed ID: 32986604
[TBL] [Abstract][Full Text] [Related]
6. Implications of anesthesia and vaccination.
Lin C; Vazquez-Colon C; Geng-Ramos G; Challa C
Paediatr Anaesth; 2021 May; 31(5):531-538. PubMed ID: 33540468
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 vaccination in our transplant recipients: The time is now.
Aslam S; Goldstein DR; Vos R; Gelman AE; Kittleson MM; Wolfe C; Danziger-Isakov L
J Heart Lung Transplant; 2021 Mar; 40(3):169-171. PubMed ID: 33487534
[TBL] [Abstract][Full Text] [Related]
8. Developing a Framework for Pandemic COVID-19 Vaccine Allocation: a Modified Delphi Consensus Study in Korea.
Choi MJ; Choi WS; Seong H; Choi JY; Kim JH; Kim YJ; Cho EY; Kim DH; Park H; Lee H; Kim NJ; Song JY; Cheong HJ; Kim SI; Peck KR
J Korean Med Sci; 2021 Jun; 36(23):e166. PubMed ID: 34128597
[TBL] [Abstract][Full Text] [Related]
9. Mini Review Immunological Consequences of Immunization With COVID-19 mRNA Vaccines: Preliminary Results.
Lombardi A; Bozzi G; Ungaro R; Villa S; Castelli V; Mangioni D; Muscatello A; Gori A; Bandera A
Front Immunol; 2021; 12():657711. PubMed ID: 33777055
[No Abstract] [Full Text] [Related]
10. COVID-19 vaccination: Recommendations for management of patients with allergy or immune-based diseases.
Peter J
S Afr Med J; 2021 Feb; 111(4):291-294. PubMed ID: 33944757
[TBL] [Abstract][Full Text] [Related]
11. Immunological surrogate endpoints of COVID-2019 vaccines: the evidence we have versus the evidence we need.
Jin P; Li J; Pan H; Wu Y; Zhu F
Signal Transduct Target Ther; 2021 Feb; 6(1):48. PubMed ID: 33531462
[TBL] [Abstract][Full Text] [Related]
12. A COVID-19 vaccine-dare to dream.
Phillis A
Br J Community Nurs; 2020 Dec; 25(12):2-7. PubMed ID: 33275510
[TBL] [Abstract][Full Text] [Related]
13. Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases.
Furer V; Rondaan C; Agmon-Levin N; van Assen S; Bijl M; Kapetanovic MC; de Thurah A; Mueller-Ladner U; Paran D; Schreiber K; Warnatz K; Wulffraat NM; Elkayam O
RMD Open; 2021 Feb; 7(1):. PubMed ID: 33627440
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive analysis of the efficacy and safety of COVID-19 vaccines.
Cai C; Peng Y; Shen E; Huang Q; Chen Y; Liu P; Guo C; Feng Z; Gao L; Zhang X; Gao Y; Liu Y; Han Y; Zeng S; Shen H
Mol Ther; 2021 Sep; 29(9):2794-2805. PubMed ID: 34365034
[TBL] [Abstract][Full Text] [Related]
15. Individual preferences for COVID-19 vaccination in China.
Leng A; Maitland E; Wang S; Nicholas S; Liu R; Wang J
Vaccine; 2021 Jan; 39(2):247-254. PubMed ID: 33328140
[TBL] [Abstract][Full Text] [Related]
16. New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.
Ura T; Yamashita A; Mizuki N; Okuda K; Shimada M
Vaccine; 2021 Jan; 39(2):197-201. PubMed ID: 33279318
[TBL] [Abstract][Full Text] [Related]
17. One Shot Wonder: A Vaccine Against All Coronaviruses.
Mertz L
IEEE Pulse; 2020; 11(6):2-5. PubMed ID: 33315546
[TBL] [Abstract][Full Text] [Related]
18. Unfolding the Determinants of COVID-19 Vaccine Acceptance in China.
Yin F; Wu Z; Xia X; Ji M; Wang Y; Hu Z
J Med Internet Res; 2021 Jan; 23(1):e26089. PubMed ID: 33400682
[TBL] [Abstract][Full Text] [Related]
19. Safety of mRNA-Based Vaccines for SARS CoV-2.
Barda B; Cerny A
Chem Res Toxicol; 2021 Aug; 34(8):1823-1825. PubMed ID: 34009959
[TBL] [Abstract][Full Text] [Related]
20. Recombinant vaccines for COVID-19.
Yadav T; Srivastava N; Mishra G; Dhama K; Kumar S; Puri B; Saxena SK
Hum Vaccin Immunother; 2020 Dec; 16(12):2905-2912. PubMed ID: 33232211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]